Role of viral and host factors in interferon based therapy of hepatitis C virus infection
about
Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective.Advanced molecular surveillance of hepatitis C virusImmunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C.Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian AboriginalMolecular epidemiology and clinical features of Hepatitis C Virus (HCV) in epidemic areas of Interior Sindh, Pakistan.Genetic polymorphisms -137 (rs187238) and -607 (rs1946518) in the interleukin-18 promoter may not be associated with development of hepatocellular carcinoma.A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges.IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.Predictive potential of IL-28B genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective.Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients.Genetic variant of IL28B rs12979860, as predictive marker of interferon-based therapy in Pakistani population.Novel Biomarkers Associated With the Outcome of Interferon-Based Hepatitis C Virus Therapy.Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.
P2860
Q26773585-946339DC-31EA-49F4-B2A3-0828ADF73D96Q28650908-4799F8A8-699F-4872-9965-A4B0098B6DA3Q33797446-B54987A9-1132-4061-9815-C44C14968887Q34163417-0F2AA30F-FBA5-4502-8DA5-5E077B76D26AQ35030432-AB321965-0525-46EC-814A-1823925D8660Q36997013-1DC86B7A-93DE-47B2-9913-8788D76F4F19Q37405493-786D4991-17BD-4246-A869-0A05745C5580Q37522290-8772CEA4-1FBC-45FC-8B19-CCF472BA573AQ37608313-AD2D6CD3-0296-4EE2-B834-AE41CF446356Q38477511-AA1E2E47-E8F4-441C-AF9B-C4390BF0DF06Q38818441-D0EA8DDE-D538-434B-8F0A-DFE183C7FDA3Q39419036-73C18150-903F-4FEA-8987-A1243CD2E153Q41471133-933117B3-B8A1-49E5-BA5D-C57FE5A2A105Q42322571-88AAC356-D6FC-4859-A871-8BBEB3205666Q47552631-8F775E54-BBCE-4BE4-A381-4219A920A549
P2860
Role of viral and host factors in interferon based therapy of hepatitis C virus infection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of viral and host factors in interferon based therapy of hepatitis C virus infection
@en
Role of viral and host factors ...... f hepatitis C virus infection.
@nl
type
label
Role of viral and host factors in interferon based therapy of hepatitis C virus infection
@en
Role of viral and host factors ...... f hepatitis C virus infection.
@nl
prefLabel
Role of viral and host factors in interferon based therapy of hepatitis C virus infection
@en
Role of viral and host factors ...... f hepatitis C virus infection.
@nl
P2093
P2860
P356
P1433
P1476
Role of viral and host factors in interferon based therapy of hepatitis C virus infection
@en
P2093
Hafiza Madeha Khaliq
Javed Ashraf
Madiha Khalid
Muhammad Imran
Muqddas Tariq
Sikandar Azam
Sobia Manzoor
P2860
P2888
P356
10.1186/1743-422X-10-299
P577
2013-10-01T00:00:00Z
P5875
P6179
1024821681